References
- Torregrosa M, Rullan MM, Clavery C, Sabater A, Gastaner A. Severe erythroblastosis in a primigravida associated with absence of Rh chromosomes. Am J Obst & Gynec 1961; 1375–8.
- Badakere SS, Bhatia HM. Haemolytic disease of the newborn in a D––/D–– Indian woman. Vox Sang 1973;24:280–2.
- Kyou SH, Hee Chung K, Kwang SH,Woo SS.A case of fatal hemolytic disease of the newborn associated with D––/D–– phenotype. Am J of Perinatology 1997; 14:495–7.
- Deitenbeck R,Tutschek B, Crombach G, Stannigel H. Successful management of pregnancy and hemolytic disease of the newborn due to anti-Hr0 in a woman of the D–– phenotype.Transfusion 1999;39:1151–2.
- Namirska-Krztón A, Fabijanska-Mitek J, Seyfried H. Enzyme linked antiglobulin test for the evaluation of the amount of IgG autoantibodies on red blood cells. Clin Lab Haematol 1995;17:221–4.
- Hadley AG, Kumpel BM, Leader KA, Poole GD, Fraser ID. Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn.Br J Haematol 1991;77:221–8.
- Hadley AG, Wilkes A, Goodrick J, Penman D, Soothill P, Lucas G.The ability of the chemiluminescence test to predict clinical outcome and the necessity for amniocenteses in pregnancies at risk of haemolytic disease of the newborn. Br J Obstet Gyneacol 1998; 105:231–4.
- Zupanska B. Assays to predict the clinical significance of blood group antibodies. Curr Opin in Hematol 1998;5:412–6.
- Zupanska B, Lenkiewicz B, Michalewska B, Rokicki T. The ability of cellular assays to predict the necessity for cordocenteses in pregnancies at risk of haemolytic disease of the newborn.Vox Sang (in press).